Literature DB >> 7615019

Monocyte-induced cytokine expression in cultured human retinal pigment epithelial cells.

G J Jaffe1, W L Roberts, H L Wong, A D Yurochko, G J Cianciolo.   

Abstract

Monocytes and retinal pigment epithelial cells are intimately associated in membranes of eyes with proliferative vitreoretinopathy and in certain types of uveitis. The goal of this study was to determine whether monocytes modulate cytokine expression in retinal pigment epithelial cells, and if so, to identify the monocyte products responsible for this effect. Cultured human retinal pigment epithelial cells were exposed to varying concentrations of monocyte-conditioned medium from unstimulated human monocytes for 1-48 hr, or from monocytes prestimulated with lipopolysaccharide. mRNA expression of interleukin-1 beta, interleukin-6, interleukin-8, melanoma growth stimulating activity/gro alpha and gamma, macrophage colony stimulating factor, transforming growth factor-beta 2, basic fibroblast growth factor and activin beta A chain was determined by reverse transcription polymerase chain reaction. Protein secretion of selected cytokines, interleukin-1 beta, interleukin-6, interleukin-8, macrophage colony stimulating factor and transforming growth factor-beta 2 was measured in RPE-conditioned medium by ELISA. Retinal pigment epithelial cells constitutively expressed mRNA for interleukin-6, macrophage colony stimulating factor, transforming growth factor-beta 2, basic fibroblast growth factor and activin beta A chain. Interleukin-1 beta, melanoma growth stimulating activity/gro alpha and gamma and interleukin-8 were not expressed under basal conditions. Stimulated monocyte-conditioned medium markedly induced mRNA of all cytokines except basic fibroblast growth factor and transforming growth factor-beta 2 in a dose- and time-dependent manner. Unstimulated monocyte-conditioned medium was a less potent inducing agent, but still enhanced mRNA expression of interleukin-6, interleukin-8 and melanoma growth stimulating activity/gro alpha. Stimulated monocyte-conditioned medium also induced a time-dependent increase in interleukin-6, Interleukin-8, macrophage colony stimulation factor and transforming growth factor-beta 2, but not interleukin-1 beta protein secretion (p < 0.05 for all time points). Neutralizing antibodies to interleukin-1 beta, or tumour necrosis factor alpha, but not interleukin-1 alpha, significantly reduced cytokine mRNA expression induced by stimulated monocyte-conditioned medium. The combination of all three neutralizing antibodies almost entirely eliminated monocyte-induced mRNA expression and protein production of all cytokines studied. Activated monocytes secrete a heterogeneous mixture of products that together strongly induce expression of multiple cytokines in human retinal pigment epithelial cells. Most if not all of the inducing effect can be accounted for by interleukin-1 beta and tumour necrosis factor alpha. Because cytokines have been implicated in proliferative vitreoretinopathy and uveitis, monocyte-mediated cytokine expression by RPE cells may serve to initiate and perpetuate these diseases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7615019     DOI: 10.1016/s0014-4835(05)80068-5

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  18 in total

1.  Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy.

Authors:  I A El-Ghrably; H S Dua; G M Orr; D Fischer; P J Tighe
Journal:  Br J Ophthalmol       Date:  2001-04       Impact factor: 4.638

2.  Microarray analysis identifies changes in inflammatory gene expression in response to amyloid-beta stimulation of cultured human retinal pigment epithelial cells.

Authors:  Khaliq H Kurji; Jing Z Cui; Tony Lin; David Harriman; Shiv S Prasad; Ljuba Kojic; Joanne A Matsubara
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-09-24       Impact factor: 4.799

3.  Polarized secretion of IL-6 and IL-8 by human retinal pigment epithelial cells.

Authors:  G M Holtkamp; M Van Rossem; A F de Vos; B Willekens; R Peek; A Kijlstra
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

4.  Cytokine regulation of granulocyte-macrophage colony-stimulating factor (GM-CSF) production by human retinal pigment epithelial cells.

Authors:  I J Crane; M C Kuppner; S McKillop-Smith; C A Wallace; J V Forrester
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

5.  Control of chemokine production at the blood-retina barrier.

Authors:  I J Crane; C A Wallace; S McKillop-Smith; J V Forrester
Journal:  Immunology       Date:  2000-11       Impact factor: 7.397

6.  Indocyanine green-assisted peeling of the epiretinal membrane in proliferative vitreoretinopathy.

Authors:  Hidehisa Sakamoto; Ichiro Yamanaka; Toshiaki Kubota; Tatsuro Ishibashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-02-20       Impact factor: 3.117

7.  Chemokine CXCL-1: activity in the vitreous during proliferative vitreoretinopathy.

Authors:  C Symeonidis; S Androudi; I Georgalas; A Tzamalis; N Chalvatzis; T Rotsos; E Souliou; E Diza; S A Dimitrakos
Journal:  Clin Exp Immunol       Date:  2015-08       Impact factor: 4.330

8.  Human RPE cell apoptosis induced by activated monocytes is mediated by caspase-3 activation.

Authors:  Susan G Elner; Ayako Yoshida; Zong-Mei Bian; Andrei L Kindezelskii; Howard R Petty; Victor M Elner
Journal:  Trans Am Ophthalmol Soc       Date:  2003

9.  Broad spectrum antiangiogenic treatment for ocular neovascular diseases.

Authors:  Ofra Benny; Kei Nakai; Takeru Yoshimura; Lauren Bazinet; James D Akula; Shintaro Nakao; Ali Hafezi-Moghadam; Dipak Panigrahy; Pouya Pakneshan; Robert J D'Amato
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

10.  Subtoxic levels hydrogen peroxide-induced production of interleukin-6 by retinal pigment epithelial cells.

Authors:  Wen-Chuan Wu; Dan-Ning Hu; Hua-Xin Gao; Min Chen; Dawei Wang; Richard Rosen; Steven A McCormick
Journal:  Mol Vis       Date:  2010-09-12       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.